Feasibility of clinical dendritic cell vaccination in acute myeloid leukemia
/in Acute Leukemia, International Publications /von 2006-07-13 / Immunobiology 2006;211(6-8):677-85Cellular immunity of patients with malignant glioma: prerequisites for dendritic cell vaccination immunotherapy
/in Glioblastoma, International Publications /von 2006-07-01 / J. Neurosurg. 2006 Jul;105(1):41-50Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice
/in Glioblastoma, International Publications /von 2006-07-01 / Neurol. Res. 2006 Jul;28(5):527-31The role of hyperthermia in combined treatment in the management of soft tissue sarcoma
/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 2006-07-01 / Curr Oncol Rep 2006 Jul;8(4):305-9Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells
/in Hepatocellular Carcinoma, International Publications /von 2006-06-30 / Cell. Immunol. 2006 Feb;239(2):144-50Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo
/in International Publications, Pancreatic Cancer /von 2006-06-13 / Int. Immunol. 2006 Aug;18(8):1279-83Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients
/in Hypernephroma, International Publications /von 2006-06-01 / Cancer Res. 2006 Jun;66(11):5910-8Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trial
/in International Publications, Prostate Cancer /von 2006-06-01 / Prostate 2006 Jun;66(8):811-21[Therapeutic effect of whole body hyperthermia combined with chemotherapy in patients with advanced cancer]
/in Gastric Cancer, Hyperthermia, International Publications, NSCLC /von 2006-06-01 / Zhong Nan Da Xue Xue Bao Yi Xue Ban 2006 Jun;31(3):350-2
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de